Watson Recalls Irregular Heartbeat Drug

Law360, New York (March 24, 2009, 12:00 AM EDT) -- Watson Pharmaceuticals Inc. said Monday that it was voluntarily recalling select batches of propafenone hydrochloride, which is used to treat irregular heartbeats.

According to Corona, Calif.-based Watson, one lot of propafenone HCL 225 mg tablets that were sold in 100-count bottles in the U.S. might contain slightly higher levels of the active ingredient than specified.

“Propafenone ... has a narrow therapeutic index, so some patients who are particularly sensitive to small variations in dose may experience potentially serious side effects, including arrhythmias (irregular heartbeat) or low...
To view the full article, register now.